Ketavita Wellness Clinic, located in Wyckoff, New Jersey, delivers medically overseen IV ketamine infusion treatments designed to address mental health disorders and persistent pain syndromes that have proven unresponsive to conventional therapeutic approaches.
Our evidence-based protocols target treatment-resistant depression, anxiety disorders, PTSD, OCD, and chronic pain conditions, offering accelerated symptom relief. We proudly serve patients throughout all of Bergen County.
Ketavita combines advanced ketamine therapy with over 25 years of medical expertise. Led by Mehdi Pouria, an internationally trained medical doctor and U.S. board-certified Advanced Practice Nurse, our clinic provides personalized care in a comfortable, spa-like environment. We serve patients throughout northern New Jersey, including Franklin Lakes, Ridgewood, Ramsey, Fair Lawn, and Paramus, offering local access to cutting-edge mental health and pain management treatments.
IV ketamine therapy at Ketavita addresses multiple conditions:
When traditional treatments fall short—when multiple medications have failed, when side effects become intolerable, or when symptoms persist despite best efforts—IV ketamine therapy offers a different mechanism of action that can provide breakthrough relief.
IV ketamine therapy at Ketavita addresses multiple conditions:
When traditional treatments fall short—when multiple medications have failed, when side effects become intolerable, or when symptoms persist despite best efforts—IV ketamine therapy offers a different mechanism of action that can provide breakthrough relief.
Ketamine is an FDA-approved medication originally developed as an anesthetic and has been used safely in medical settings for decades. At subanesthetic doses (much lower than anesthetic levels), ketamine demonstrates remarkable antidepressant and pain-relieving properties. This off-label use for treatment-resistant depression and chronic pain has been extensively studied and shows response rates up to 70%, significantly higher than traditional antidepressants.
IV ketamine differs fundamentally from conventional antidepressants. While traditional medications target serotonin, norepinephrine, or dopamine systems and take weeks to show effects, ketamine works through a completely different pathway—the glutamate system—and often provides noticeable improvement within hours to days.
Ketamine blocks NMDA receptors in the brain, which increases glutamate activity and promotes the formation of new neural connections. This process, called neuroplasticity, helps reset disrupted brain patterns associated with depression, anxiety, and chronic pain. Unlike traditional medications that slowly build up in your system, ketamine’s unique mechanism produces rapid-acting effects.
For mental health conditions, ketamine helps restore balance to neural pathways involved in mood regulation, often providing relief when other treatments have failed. For chronic pain, ketamine interrupts sensitized pain pathways and helps reset the nervous system’s response to pain signals, offering relief that extends beyond the infusion itself.
Initial Consultation: Your journey begins with a comprehensive evaluation of your health history, current symptoms, previous treatments, and treatment goals. We’ll determine if IV ketamine therapy is appropriate for your specific condition and create a personalized treatment plan.
Treatment Protocol: Most patients receive an initial series of 6 infusions over 2-3 weeks. Mental health treatments typically involve infusions lasting 40 minutes, while chronic pain protocols may extend up to 4 hours depending on your condition.
During Your Infusion: You’ll be in a comfortable, private treatment room with a small IV line placed in your arm. The ketamine flows steadily throughout your session. You remain awake but may experience mild dissociative effects—a feeling of being slightly detached from your surroundings. This is normal, temporary, and closely monitored by our medical team.
Post-Treatment: After your infusion, you’ll spend time recovering in our clinic before being cleared to leave. Many patients feel noticeably calmer or experience mood improvement within hours. You’ll need someone to drive you home, as you should not drive for the remainder of the day.
Maintenance Treatment: After the initial series, many patients benefit from maintenance infusions every 4-6 weeks to sustain therapeutic effects.
Patient safety is our highest priority. Every IV ketamine infusion is administered under the direct supervision of experienced medical professionals. We use pharmaceutical-grade ketamine and maintain rigorous protocols for dosing, monitoring, and patient care. Our comfortable, private infusion rooms provide a calming environment designed to reduce anxiety and support healing.
We monitor your vital signs throughout treatment and remain available for any questions or concerns during and after your infusion. Our approach emphasizes both physical safety and emotional support, ensuring you feel cared for throughout your treatment journey.
IV ketamine therapy is typically not covered by insurance as it’s used off-label for mental health and pain conditions. We charge $475 per session, with a package of 6 sessions available for $2,400. Your initial consultation and evaluation are completely free. We accept all standard payment methods and can provide documentation if you wish to pursue insurance reimbursement (additional $50 fee), though coverage is not guaranteed.
Your initial phone consultation is free of charge. During this 20-45 minute conversation, we’ll answer your questions, determine if you’re a good candidate, and discuss costs and treatment protocols.
If you’ve been struggling with treatment-resistant depression, anxiety, PTSD, OCD, or chronic pain, IV ketamine therapy at Ketavita may offer the breakthrough you’ve been seeking.
Call us at (201) 588-6471 or contact us online to schedule your free consultation.
Wilkinson ST, Ballard ED, Bloch MH, et al. Ketamine treatment for depression: a review. Translational Psychiatry. 2022;12:127. https://pmc.ncbi.nlm.nih.gov/articles/PMC9010394/
Fava M, Freeman MP, Flynn M, et al. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD). Molecular Psychiatry. 2020;25:1592-1603. https://www.nature.com/articles/s41380-018-0256-5
Ketamine Therapy
Our Treatments
365 Franklin Avenue, Wyckoff, NJ 07481